Vanessa Malier

Vanessa Malier is a life sciences executive and advisor serving as Chair of the Board at Nuage Therapeutics and a non-executive director at Sygnature Discovery in Paris, France. She previously spent a decade as a Managing Partner at Kurma Partners, where she executed five recorded investments ranging from $100,000 to $5 million across pre-seed to Series B stages. During her tenure, she helped scale the venture capital firm and successfully raise capital for its Biofund III and subsequent growth funds. Prior to venture capital, Malier worked for fifteen years in pharmaceuticals, including ten years at Ipsen in roles like Chief of Staff to the CEO and Vice President of R&D Strategic Planning. Educated at the Institut Pasteur, her current focus remains on advancing healthcare, diagnostics, and therapeutics through strategic biotech investments and board advisory roles.